ALLERGAN SALES, LLC v. SANDOZ, INC.
Before Prost, Newman, and Wallach. Appeal from the United States District Court for the District of New Jersey.
Summary: A “wherein” clause can be limiting if it is material to...more
Federal Circuit Summary -
Before Prost, Reyna, and Taranto. Appeal from the U.S. District Court for the District of Maryland.
Summary: An abstract idea cannot be used to supply an inventive concept that renders a claim...more
Federal Circuit Summary -
Before Prost, Schall, and Chen. Appeal from the Patent Trial and Appeal Board.
Summary: The plain language of 35 U.S.C. § 311(a) unambiguously leaves no room for assignor estoppel to apply in...more
11/13/2018
/ 35 U.S.C. § 311(a) ,
Appeals ,
Assignor Estoppel ,
Claim Construction ,
Cross-Appeals ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Validity ,
Patents ,
Reaffirmation ,
Remand ,
Reversal
Federal Circuit Summary -
Before Dyk, Moore, and Reyna. Appeal from the Patent Trial and Appeal Board.
Summary: Tribal sovereign immunity does not shield Indian Tribe owned patents from IPR. ...more
7/25/2018
/ Adjudicatory Process ,
Administrative Agencies ,
Administrative Proceedings ,
Allergan Inc ,
Appeals ,
Enforcement Actions ,
Generic Drugs ,
Inter Partes Review (IPR) Proceeding ,
IP Assignment Agreements ,
Motion to Dismiss ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Sovereign Immunity ,
Tribal Governments
Federal Circuit Summaries -
Before Newman, Clevenger, and Wallach. Appeal from the Patent Trial and Appeal Board.
Summary: The USPTO has standing to intervene to defend its decision, even when the requestor has...more